Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in serum uteroglobin level in type 2 diabetes mellitus patients.
Lim JY, Ju SH, Kim JM, Yi HS, Lee JH, Kim HJ, Ku BJ, Joung KH. Lim JY, et al. Among authors: yi hs. Front Endocrinol (Lausanne). 2024 Sep 30;15:1416326. doi: 10.3389/fendo.2024.1416326. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39403586 Free PMC article.
T-Cell Senescence in Human Metabolic Diseases.
Nga HT, Nguyen TL, Yi HS. Nga HT, et al. Among authors: yi hs. Diabetes Metab J. 2024 Sep;48(5):864-881. doi: 10.4093/dmj.2024.0140. Epub 2024 Aug 28. Diabetes Metab J. 2024. PMID: 39192822 Free PMC article. Review.
Metabolic Reprogramming in Thyroid Cancer.
Ju SH, Song M, Lim JY, Kang YE, Yi HS, Shong M. Ju SH, et al. Among authors: yi hs. Endocrinol Metab (Seoul). 2024 Jun;39(3):425-444. doi: 10.3803/EnM.2023.1802. Epub 2024 Jun 10. Endocrinol Metab (Seoul). 2024. PMID: 38853437 Free PMC article. Review.
Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial.
Ju SH, Lim JY, Song M, Kim JM, Kang YE, Yi HS, Joung KH, Lee JH, Kim HJ, Ku BJ. Ju SH, et al. Among authors: yi hs. Front Endocrinol (Lausanne). 2024 Mar 22;15:1336357. doi: 10.3389/fendo.2024.1336357. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38586464 Free PMC article. Clinical Trial.
Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma.
Kim Y, Jung KY, Kim YH, Xu P, Kang BE, Jo Y, Pandit N, Kwon J, Gariani K, Gariani J, Lee J, Verbeek J, Nam S, Bae SJ, Ha KT, Yi HS, Shong M, Kim KH, Kim D, Jung HJ, Lee CW, Kim KR, Schoonjans K, Auwerx J, Ryu D. Kim Y, et al. Among authors: yi hs. Drug Resist Updat. 2024 Mar;73:101054. doi: 10.1016/j.drup.2024.101054. Epub 2024 Jan 17. Drug Resist Updat. 2024. PMID: 38277756 Free PMC article.
168 results